SUPN Supernus Pharmaceuticals Inc
$28.61
Supernus Pharmaceuticals Inc (SUPN) Earnings News
Earnings press releases, previews and reviews for Supernus Pharmaceuticals Inc (SUPN), newest first. Our most recent is review: Supernus Ends Its Standalone Era With a Big Beat and Higher Guidance, but the Indivior Merger Now Drives the Story.
Thursday
October 29, 2026
6:38 PM ET
Supernus Ends Its Standalone Era With a Big Beat and Higher Guidance, but the Indivior Merger Now Drives the Story
Earnings Whispers · Review
Thursday
October 29, 2026
4:05 PM ET
Supernus Announces Third Quarter 2026 Financial Results
Thursday
October 22, 2026
6:55 AM ET
Supernus Must Prove Its Standalone Engine Still Hums as Indivior Merger Nears
Earnings Whispers · Preview
Monday
October 19, 2026
8:30 AM ET
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
Monday
August 3, 2026
6:35 AM ET
Supernus Announces Second Quarter 2026 Financial Results
Wednesday
July 22, 2026
5:05 PM ET
Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026